Karyopharm to participate at jefferies london healthcare conference

Newton, mass., nov. 11, 2021 /prnewswire/ -- karyopharm therapeutics inc. (nasdaq:kpti), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that richard paulson, president and chief executive officer of karyopharm, will participate in a fireside chat at the jefferies london healthcare conference.
KPTI Ratings Summary
KPTI Quant Ranking